Reviewer: SONG Yu-qin, Literature Co-worker: CAI Qi-chun. The Beginning of Non-Chemotherapy Era: Lenalidomide plus Rituximab as First-Line Therapy for Mantle-Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2016, 16(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2016.02.007
|
Citation:
|
Reviewer: SONG Yu-qin, Literature Co-worker: CAI Qi-chun. The Beginning of Non-Chemotherapy Era: Lenalidomide plus Rituximab as First-Line Therapy for Mantle-Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2016, 16(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2016.02.007
|
Reviewer: SONG Yu-qin, Literature Co-worker: CAI Qi-chun. The Beginning of Non-Chemotherapy Era: Lenalidomide plus Rituximab as First-Line Therapy for Mantle-Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2016, 16(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2016.02.007
|
Citation:
|
Reviewer: SONG Yu-qin, Literature Co-worker: CAI Qi-chun. The Beginning of Non-Chemotherapy Era: Lenalidomide plus Rituximab as First-Line Therapy for Mantle-Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2016, 16(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2016.02.007
|
DownLoad: